{"title": "Predicting the epidemic trend of COVID-19 in China and across the world using the machine learning approach", "doi": "10.1101/2020.03.18.20038117", "citation_id": "2020.03.18.20038117v1", "date": "2020-03-20", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.18.20038117", "abstract": "<p>Background: Although the COVID-19 has been well controlled in China, it is rapidly spreading outside China that may lead to catastrophic results globally without implementation of necessary mitigation measures. Because the COVID-19 outbreak has made comprehensive and profound impacts on the world, an accurate prediction of its epidemic trend is significant. Although many studies have predicted the COVID-19 epidemic trend, most of these studies have used the early stage data and focused on the China cases. \nMethods: We predicted the COVID-19 epidemic trend in China and across the world using the machine learning approach. We first built the models for predicting the daily numbers of cumulative confirmed cases (CCCs), new cases (NCs), and death cases (DCs) of COVID-19 in China based on the data from Jan 20, 2020, to Mar 1, 2020. Furthermore, we built the models, derived from the models for the China cases, for predicting the epidemic trend across the world (outside China). \nFindings: The COVID-19 outbreak will peak on Feb 22, 2020 in China and April 10, 2020 across the world. It will be basically under control early April, 2020 in China and mid-June, 2020 across the world. The total number of COVID-19 cases will reach around 89, 000 in China and 403,000 across the world during the epidemic. Around 4,000 and 18,300 people will died of COVID-19 in China and across the world, respectively. The COVID-19 mortality rate is estimated to be around 4% all over the world.  \nInterpretation: The COVID-19 outbreak is controllable in the foreseeable future if comprehensive and stringent control measures are taken.</p>", "twitter_description": "Background: Although the COVID-19 has been well controlled in China, it is rapidly spreading outside China that may lead to catastrophic results globally without implementation of necessary mitigation measures. Because the COVID-19 outbreak has made comprehensive and profound impacts on the world, an accurate prediction of its epidemic trend is significant. Although many studies have predicted the COVID-19 epidemic trend, most of these studies have used the early stage data and focused on the China cases. Methods: We predicted the COVID-19 epidemic trend in China and across the world using the machine learning approach. We first built the models for predicting the daily numbers of cumulative confirmed cases (CCCs), new cases (NCs), and death cases (DCs) of COVID-19 in China based on the data from Jan 20, 2020, to Mar 1, 2020. Furthermore, we built the models, derived from the models for the China cases, for predicting the epidemic trend across the world (outside China). Findings: The COVID-19 outbreak will peak on Feb 22, 2020 in China and April 10, 2020 across the world. It will be basically under control early April, 2020 in China and mid-June, 2020 across the world. The total number of COVID-19 cases will reach around 89, 000 in China and 403,000 across the world during the epidemic. Around 4,000 and 18,300 people will died of COVID-19 in China and across the world, respectively. The COVID-19 mortality rate is estimated to be around 4% all over the world. Interpretation: The COVID-19 outbreak is controllable in the foreseeable future if comprehensive and stringent control measures are taken.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nThis work was supported by the China Pharmaceutical University (grant numbers 3150120001 to XW).\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nWe downloaded the statistics of confirmed COVID-19 cases in China from the National Health Committee of China (http://www.nhc.gov.cn/), including the daily numbers of CCCs, NCs, and DCs since January 20, 2020. The data for the statistics of confirmed COVID-19 cases outside China were downloaded from Worldometer (https://www.worldometers.info/coronavirus/#countries).", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.18.20038117v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.18.20038117v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.18.20038117v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/20/2020.03.18.20038117.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.18.20038117v1", "access_rights": "restricted", "authors": ["Mengyuan Li", "Zhilan Zhang", "Shanmei Jiang", "Qian Liu", "Canping Chen", "Yue Zhang", "Xiaosheng Wang"]}